Publication:
Clinicopathological Data's of Advanced NSCLC Patients with ROS1 Gene Rearrangement and of Clinical Responses to Crizotinib in TURKEY

dc.contributor.authorsOz, Buge; Batur, Sebnem; Eralp, Yesim; Hasturk, Serap; Yumuk, Fulden; Yildiz, Ozcan; Karaoglu, Aziz
dc.date.accessioned2022-03-10T17:53:51Z
dc.date.accessioned2026-01-10T20:25:09Z
dc.date.available2022-03-10T17:53:51Z
dc.date.issued2015
dc.identifier.doidoiWOS:000370365103329
dc.identifier.eissn1556-1380
dc.identifier.issn1556-0864
dc.identifier.urihttps://hdl.handle.net/11424/221749
dc.identifier.wosWOS:000370365103329
dc.language.isoeng
dc.publisherELSEVIER SCIENCE INC
dc.relation.ispartofJOURNAL OF THORACIC ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectros1 rearrangement
dc.subjectnonsmall cell lung cancer
dc.subjectcrizotinib treatment
dc.titleClinicopathological Data's of Advanced NSCLC Patients with ROS1 Gene Rearrangement and of Clinical Responses to Crizotinib in TURKEY
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPageS695
oaire.citation.issue9
oaire.citation.startPageS695
oaire.citation.titleJOURNAL OF THORACIC ONCOLOGY
oaire.citation.volume10

Files